Skip to Main content Skip to Navigation
Journal articles

Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.

Document type :
Journal articles
Complete list of metadatas

https://hal.univ-brest.fr/hal-00689153
Contributor : Ghislaine Calvez <>
Submitted on : Thursday, April 19, 2012 - 1:40:29 PM
Last modification on : Thursday, November 29, 2018 - 4:09:30 PM

Identifiers

  • HAL Id : hal-00689153, version 1
  • PUBMED : 16533732

Collections

Citation

Aurelien Delluc, Elisabeth Pasquier, Luc de Saint Martin, Dominique Mottier. Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.. Haematologica, Ferrata Storti Foundation, 2006, 91 (3), pp.ECR05. ⟨hal-00689153⟩

Share

Metrics